Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Aug 7, 2018
| Erik Komendant
Pharmaceutical Patent Abuse: To Infinity and Beyond!
Video
Aug 3, 2018
| Erica Klinger
AAM CEO Chip Davis Personal Invite to GRx+Biosims 2018
Blog
Aug 1, 2018
| Sara Skubikowski
Patients Can See Their Savings
Video
Jul 31, 2018
| Erica Klinger
Christine Simmon Reacts to the Release of FDA's Biosimilars Action Plan
Blog
Jul 26, 2018
| Rachel Schwartz
Keon is Playing Hip Hop in NYC
Blog
Jul 23, 2018
| Rachel Schwartz
Ariel is a Cancer Thriver
Press Release
Jul 19, 2018
| Allen Goldberg
AAM Statement on Importation Task Force
Press Release
Jul 18, 2018
| Allen Goldberg
AAM Statement on FDA’s Biosimilars Action Plan
Video
Jul 16, 2018
| Erica Klinger
Highlights from Craig Burton on the Newly Released 2018 Generic Drug Access & Savings Report
Press Release
Jul 16, 2018
| Allen Goldberg
AAM Provides Comments in Response to Administration’s Blueprint on Drug Pricing
Fact Sheet
Jul 13, 2018
| Kristin Murphy
How to Talk About Drug Prices
Press Release
Jul 10, 2018
| Rachel Schwartz
Generic Drug Competition Lowers Prescription Cost to $6 on Average, Study Finds
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action